Events February 08, 2018 - February 09, 2018
Georgetown University
Washington, DC

How to Ensure Investment is Made in Potential New Uses for Existing Medicines for the Benefit of Patients Worldwide Conference

In December of 2015, Teva participated in a conference that was held at the Washington University in Seattle. The title of the conference was: “Future of Innovation in Medicine - Incentives for New Medical Treatments and Global Health”. This conference, “How to Ensure Investment is Made in Potential New Uses for Existing Medicines for the Benefit of Patients Worldwide”, was a continuation conference. It put more emphasis on payers perspective and on government affair participants in order to move the discussion a phase forward and address additional issues that relate to repurposing of known drugs, including Price and Reimbursement processes. Like the previous one, this conference was also co-organized with Novartis and hosted by Sr. Robin Jacob. Goodwin was a sponsor of this conference. Elaine Blais and Sarah Frederick moderated panel discussions.